Virginia Beach, United States
The company's specialties lie in their MedTech focus, IVD expertise, and an results-oriented approach, with an impressive 94% client satisfaction rate compared to other CROs. With a track record that spans 500+ regulatory submissions, 4,000+ clinical study sites, 1,000+ clinical trials, and a network of 2,600+ clinical professionals in over 50 countries, Beaufort CRO's experience and capacity are indeed remarkable.
Founded in 2004, the company operates in the Biotechnology and Medical Devices industries from its headquarters in the United States. Currently, there is no publicly disclosed information about their last investment or the investors involved. Beaufort CRO presents a compelling opportunity for investors seeking exposure to the thriving MedTech sector and the ever-evolving field of clinical research and development.
